We use non-essential cookies (including anonymous analytics) to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential for our platform to work and help us to provide you with the best experience possible. You can accept or reject our non-essential cookies and change your mind at any time. To learn more, please read our cookies policy.

Update cookie preferences

Cary Wakefield

Chief Executive



Cary Wakefield joined Ovarian Cancer Action in 2018, bringing a wealth of experience spanning FTSE, Public Sector and not-for-profit organisations in the UK and Europe. She started her career working on healthcare at GSK and has held marketing and customer insight leadership roles at the likes of the BBC, BskyB, The Economist, Freeview and EMI, successfully innovating and developing well known household brands. She is also a Non Exec Director at Peabody Trust, one of the largest housing associations in the UK.

Cary is leading Ovarian Cancer Action’s ambitious strategy to transform 10-year survival rates, so that by 2032 at least half of all women diagnosed with ovarian cancer live beyond their diagnosis.

She is passionate about women’s health and using her extensive experience to ensure that Ovarian Cancer Action creates noise, provokes thought, and leads change in healthcare and education to break down barriers in diagnosis and treatment. Combined with the charity’s investment in outstanding clinical and scientific research, Cary believes this will enable breakthroughs that give all women the very best chance of survival.

Contact details

020 7380 1730